Three-dimensional printed strontium-containing mesoporous bioactive glass scaffolds for repairing rat critical-sized calvarial defects

Acta Biomaterialia

Volumn 12, Issue 1, 2015, Pages 270-280

  Zhao, Shichang ^a   Zhang, Jianhua ^b   Zhu, Min ^b   Zhang, Yadong ^a   Liu, Zhongtang ^c   Tao, Cuilian ^b   Zhu, Yufang ^b   Zhang, Changqing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF SHANGHAI FOR SCIENCE AND TECHNOLOGY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

3 D printing; Bone regeneration; In vivo; Mesoporous bioactive glass; Strontium

Indexed keywords

3D PRINTERS; APATITE; BIOACTIVE GLASS; BLOOD VESSELS; BONE; CELL PROLIFERATION; COMPRESSIVE STRENGTH; DEFECTS; GENE EXPRESSION; MESOPOROUS MATERIALS; PHOSPHATASES; REPAIR; SCAFFOLDS (BIOLOGY); STRONTIUM; TISSUE REGENERATION;

3-D PRINTING; APATITE FORMING; BONE REGENERATION; CALVARIAL DEFECTS; FORMING ABILITY; GLASS SCAFFOLDS; IN-VIVO; MESOPOROUS BIOACTIVE GLASS; OSSEOINTEGRATION; OSTEOGENIC;

RATS;

ALKALINE PHOSPHATASE; APATITE; BIOMATERIAL; CALCIUM ION; GLASS; MESOPOROUS BIOACTIVE GLASS; OXYGEN; PHOSPHORUS; SILICONE; STRONTIUM; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; NANOFABRICATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; POROSITY; PRIORITY JOURNAL; RAT; SKULL DEFECT; THREE DIMENSIONAL PRINTING; 3T3 CELL LINE; ANIMAL; CHEMISTRY; CONGENITAL MALFORMATION; CYTOLOGY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; SCANNING ELECTRON MICROSCOPY; SKULL; TISSUE SCAFFOLD;

LAKE VICTORIA MARBURGVIRUS; RATTUS;

3T3 CELLS; ANIMALS; BIOCOMPATIBLE MATERIALS; GLASS; MICE; MICROSCOPY, ELECTRON, SCANNING; OSTEOBLASTS; RATS; SKULL; STRONTIUM; TISSUE SCAFFOLDS; X-RAY MICROTOMOGRAPHY;

EID: 84924935041     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.10.015     Document Type: Article

References (51)

1. Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC Med 2011;9:66.
2. Arcos D, Izquierdo-Barba I, Vallet-Regi M. Promising trends of bioceramics in the biomaterials field. J Mater Sci Mater Med 2009;20:447-55.
3. Rezwan K, Chen Q, Blaker JJ, Boccaccini AR. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27:3413-31.
4. Guarino V, Causa F, Ambrosio L. Bioactive scaffolds for bone and ligament tissue. Expert Rev Med Devices 2007;4:405-18.
5. Ghosh S, Parker ST, Wang X, Kaplan DL, Lewis JA. Direct-write assembly of microperiodic silk fibroin scaffolds for tissue engineering applications. Adv Funct Mater 2008;18:1883-9.
6. Therriault D, White SR, Lewis JA. Chaotic mixing in three-dimensional microvascular networks fabricated by direct-write assembly. Nat Mater 2003;2:265-71.
7. Wu C, Luo Y, Cuniberti G, Xiao Y, Gelinsky M. Three-dimensional printing of hierarchical and tough mesoporous bioactive glass scaffolds with a controllable pore architecture, excellent mechanical strength and mineralization ability. Acta Biomater 2011;7:2644-50.
8. Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004;350:459-68.
9. Yang F, Yang D, Tu J, Zheng Q, Cai L, Wang L. Strontium enhances osteogenic differentiation of mesenchymal stem cells and in vivo bone formation by activating wnt/catenin signaling. Stem Cells 2011;29:981-91.
10. Peng S, Liu X, Huang S, Li Z, Pan H, Zhen W, et al. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Bone 2011;49:1290-8.
11. Chung CJ, Long HY. Systematic strontium substitution in hydroxyapatite coatings on titanium via micro-arc treatment and their osteoblast/osteoclast responses. Acta Biomater 2011;7:4081-7.
12. Peng S, Zhou G, Luk KD, Cheung KM, Li Z, Lam WM, et al. Strontium promotes osteogenic differentiation of mesenchymal stem cells through the Ras/MAPK signaling pathway. Cell Physiol Biochem 2009;23:165-74.
13. Marie PJ, Felsenberg D, Brandi ML. How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis. Osteoporos Int 2011;22:1659-67.
14. Li Y, Li Q, Zhu S, Luo E, Li J, Feng G, et al. The effect of strontium-substituted hydroxyapatite coating on implant fixation in ovariectomized rats. Biomaterials 2010;31:9006-14.
15. Saidak Z, Marie PJ. Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis. Pharmacol Ther 2012;136:216-26.
16. Lin K, Liu P, Wei L, Zou Z, Zhang W, Qian Y, et al. Strontium substituted hydroxyapatite porous microspheres: surfactant-free hydrothermal synthesis, enhanced biological response and sustained drug release. Chem Eng J 2013;222:49-59.
17. Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, et al. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum 2008;58:1687-95.
18. Schrooten I, Behets GJ, Cabrera WE, Vercauteren SR, Lamberts LV, Verberckmoes SC, et al. Dose-dependent effects of strontium on bone of chronic renal failure rats. Kidney Int 2003;63:927-35.
19. Cohen-Solal M. Strontium overload and toxicity: impact on renal osteodystrophy. Nephrol Dial Transplant 2002;17(Suppl. 2):30-4.
20. Yan X, Huang X, Yu C, Deng H, Wang Y, Zhang Z, et al. The in-vitro bioactivity of mesoporous bioactive glasses. Biomaterials 2006;27:3396-403.
21. Alcaide M, Portoles P, Lopez-Noriega A, Arcos D, Vallet-Regi M, Portoles MT. Interaction of an ordered mesoporous bioactive glass with osteoblasts, fibroblasts and lymphocytes, demonstrating its biocompatibility as a potential bone graft material. Acta Biomater 2010;6:892-9.
22. Leonova E, Izquierdo-Barba I, Arcos D, Lopez-Noriega A, Hedin N, Vallet-Regi M, et al. Multinuclear solid-state NMR studies of ordered mesoporous bioactive glasses. J Phys Chem C 2008;112:5552-62.
23. Wu C, Zhou Y, Lin C, Chang J, Xiao Y. Strontium-containing mesoporous bioactive glass scaffolds with improved osteogenic/cementogenic differentiation of periodontal ligament cells for periodontal tissue engineering. Acta Biomater 2012;8:3805-15.
24. Han P, Wu C, Chang J, Xiao Y. The cementogenic differentiation of periodontal ligament cells via the activation of Wnt/beta-catenin signalling pathway by Li+ ions released from bioactive scaffolds. Biomaterials 2012;33:6370-9.
25. Wu C, Zhou Y, Xu M, Han P, Chen L, Chang J, et al. Copper-containing mesoporous bioactive glass scaffolds with multifunctional properties of angiogenesis capacity, osteostimulation and antibacterial activity. Biomaterials 2013;34:422-33.
26. Zhu Y, Zhang Y, Wu C, Fang Y, Yang J, Wang S. The effect of zirconium incorporation on the physiochemical and biological properties of mesoporous bioactive glasses scaffolds. Microporous Mesoporous Mater 2011;143:311-9.
27. Zhang J, Zhao S, Zhu Y, Huang Y, Zhu M, Tao C, et al. Three-dimensional printing of strontium-containing mesoporous bioactive glass scaffolds for bone regeneration. Acta Biomater 2014;10:2269-81.
28. Wei L, Ke J, Prasadam I, Miron RJ, Lin S, Xiao Y, et al. A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects. Osteoporos Int 2014;25:2089-96.
29. Zhang Y, Wei L, Wu C, Miron RJ. Periodontal regeneration using strontiumloaded mesoporous bioactive glass scaffolds in osteoporotic rats. PLoS One 2014;9:e104527.
30. Zou D, Zhang Z, He J, Zhu S, Wang S, Zhang W, et al. Repairing critical-sized calvarial defects with BMSCs modified by a constitutively active form of hypoxia-inducible factor-1alpha and a phosphate cement scaffold. Biomaterials 2011;32:9707-18.
31. Xia W, Chang J. Well-ordered mesoporous bioactive glasses (MBG): a promising bioactive drug delivery system. J Controlled Release 2006;110:522-30.
32. Luo Y, Wu C, Lode A, Gelinsky M. Hierarchical mesoporous bioactive glass/alginate composite scaffolds fabricated by three-dimensional plotting for bone tissue engineering. Biofabrication 2013;5:015005.
33. Chun JY, Kang HK, Jeong L, Kang YO, Oh JE, Yeo IS, et al. Epidermal cellular response to poly(vinyl alcohol) nanofibers containing silver nanoparticles. Colloids Surf, B 2010;78:334-42.
34. Jones JR, Hench LL. Factors affecting the structure and properties of bioactive foam scaffolds for tissue engineering. J Biomed Mater Res B Appl Biomater 2004;68:36-44.
35. Wang X, Li Y, Wei J, de Groot K. Development of biomimetic nanohydroxyapatite/poly(hexamethylene adipamide) composites. Biomaterials 2002;23:4787-91.
36. Loty C, Sautier JM, Boulekbache H, Kokubo T, Kim HM, Forest N. In vitro bone formation on a bone-like apatite layer prepared by a biomimetic process on a bioactive glass-ceramic. J Biomed Mater Res 2000;49:423-34.
37. Yan X, Yu C, Zhou X, Tang J, Zhao D. Highly ordered mesoporous bioactive glasses with superior in vitro bone-forming bioactivities. Angew Chem Int Ed Engl 2004;43:5980-4.
38. Ramaswamy Y, Wu C, Zhou H, Zreiqat H. Biological response of human bone cells to zinc-modified Ca-Si-based ceramics. Acta Biomater 2008;4:1487-97.
39. Beresford JN, Graves SE, Smoothy CA. Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation? Am J Med Genet 1993;45:163-78.
40. Valerio P, Pereira MM, Goes AM, Leite MF. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials 2004;25:2941-8.
41. Silver IA, Deas J, Erecinska M. Interactions of bioactive glasses with osteoblasts in vitro: effects of 45S5 Bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability. Biomaterials 2001;22:175-85.
42. Xynos ID, Edgar AJ, Buttery LD, Hench LL, Polak JM. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 2001;55:151-7.
43. Bonnelye E, Chabadel A, Saltel F, Jurdic P. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008;42:129-38.
44. Chattopadhyay N, Quinn SJ, Kifor O, Ye C, Brown EM. The calcium-sensing receptor (CaR) is involved in strontium ranelate-induced osteoblast proliferation. Biochem Pharmacol 2007;74:438-47.
45. Hurtel-Lemaire AS, Mentaverri R, Caudrillier A, Cournarie F, Wattel A, Kamel S, et al. The calcium-sensing receptor is involved in strontium ranelate-induced osteoclast apoptosis. New insights into the associated signaling pathways. J Biol Chem 2009;284:575-84.
46. Barbara A, Delannoy P, Denis BG, Marie PJ. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism 2004;53:532-7.
47. Caverzasio J. Strontium ranelate promotes osteoblastic cell replication through at least two different mechanisms. Bone 2008;42:1131-6.
48. Fromigue O, Hay E, Barbara A, Marie PJ. Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate. J Biol Chem 2010;285:25251-8.
49. Peng S, Liu X, Wang T, Li Z, Zhou G, Luk KD, et al. In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells. J Orthop Res 2010;28:1208-14.
50. Gu Z, Zhang X, Li L, Wang Q, Yu X, Feng T. Acceleration of segmental bone regeneration in a rabbit model by strontium-doped calcium polyphosphate scaffold through stimulating VEGF and bFGF secretion from osteoblasts. Mater Sci Eng, C (Mater Biol Appl) 2013;33:274-81.
51. Lin K, Xia L, Li H, Jiang X, Pan H, Xu Y, et al. Enhanced osteoporotic bone regeneration by strontium-substituted calcium silicate bioactive ceramics. Biomaterials 2013;34:10028-42.